Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

Vassilios Papadopoulos, Mario Baraldi, Tomás R. Guilarte, Thomas B. Knudsen, Jean Jacques Lacapère, Peter Lindemann, Michael D Norenberg, David Nutt, Abraham Weizman, Ming Rong Zhang, Moshe Gavish

Research output: Contribution to journalArticle

941 Citations (Scopus)

Abstract

The peripheral-type benzodiazepine receptor or recognition site (PBR) is a widely distributed transmembrane protein that is located mainly in the outer mitochondrial membrane. The PBR binds to high-affinity drug ligands and cholesterol. Many functions are associated directly or indirectly with the PBR, including the regulation of cholesterol transport and the synthesis of steroid hormones, porphyrin transport and heme synthesis, apoptosis, cell proliferation, anion transport, regulation of mitochondrial functions and immunomodulation. Based on these functions, there are many potential clinical applications of PBR modulation, such as in oncologic, endocrine, neuropsychiatric and neurodegenerative diseases. Although 'PBR' is a widely used and accepted name in the scientific community, recent data regarding the structure and molecular function of this protein increasingly support renaming it to represent more accurately its subcellular role (or roles) and putative tissue-specific function (or functions). Translocator protein (18 kDa) is proposed as a new name, regardless of the subcellular localization of the protein.

Original languageEnglish
Pages (from-to)402-409
Number of pages8
JournalTrends in Pharmacological Sciences
Volume27
Issue number8
DOIs
StatePublished - Aug 1 2006

Fingerprint

GABA-A Receptors
Terminology
Molecular Structure
Names
Proteins
Cholesterol
Endocrine System Diseases
Steroid hormones
Immunomodulation
Neurodegenerative diseases
Porphyrins
Mitochondrial Membranes
Heme
Neurodegenerative Diseases
Anions
Cell proliferation
Steroids
Cell Proliferation
Hormones
Apoptosis

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Translocator protein (18 kDa) : new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. / Papadopoulos, Vassilios; Baraldi, Mario; Guilarte, Tomás R.; Knudsen, Thomas B.; Lacapère, Jean Jacques; Lindemann, Peter; Norenberg, Michael D; Nutt, David; Weizman, Abraham; Zhang, Ming Rong; Gavish, Moshe.

In: Trends in Pharmacological Sciences, Vol. 27, No. 8, 01.08.2006, p. 402-409.

Research output: Contribution to journalArticle

Papadopoulos, V, Baraldi, M, Guilarte, TR, Knudsen, TB, Lacapère, JJ, Lindemann, P, Norenberg, MD, Nutt, D, Weizman, A, Zhang, MR & Gavish, M 2006, 'Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function', Trends in Pharmacological Sciences, vol. 27, no. 8, pp. 402-409. https://doi.org/10.1016/j.tips.2006.06.005
Papadopoulos, Vassilios ; Baraldi, Mario ; Guilarte, Tomás R. ; Knudsen, Thomas B. ; Lacapère, Jean Jacques ; Lindemann, Peter ; Norenberg, Michael D ; Nutt, David ; Weizman, Abraham ; Zhang, Ming Rong ; Gavish, Moshe. / Translocator protein (18 kDa) : new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. In: Trends in Pharmacological Sciences. 2006 ; Vol. 27, No. 8. pp. 402-409.
@article{6cd3a571e8c048c9835dbe6695df2a17,
title = "Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function",
abstract = "The peripheral-type benzodiazepine receptor or recognition site (PBR) is a widely distributed transmembrane protein that is located mainly in the outer mitochondrial membrane. The PBR binds to high-affinity drug ligands and cholesterol. Many functions are associated directly or indirectly with the PBR, including the regulation of cholesterol transport and the synthesis of steroid hormones, porphyrin transport and heme synthesis, apoptosis, cell proliferation, anion transport, regulation of mitochondrial functions and immunomodulation. Based on these functions, there are many potential clinical applications of PBR modulation, such as in oncologic, endocrine, neuropsychiatric and neurodegenerative diseases. Although 'PBR' is a widely used and accepted name in the scientific community, recent data regarding the structure and molecular function of this protein increasingly support renaming it to represent more accurately its subcellular role (or roles) and putative tissue-specific function (or functions). Translocator protein (18 kDa) is proposed as a new name, regardless of the subcellular localization of the protein.",
author = "Vassilios Papadopoulos and Mario Baraldi and Guilarte, {Tom{\'a}s R.} and Knudsen, {Thomas B.} and Lacap{\`e}re, {Jean Jacques} and Peter Lindemann and Norenberg, {Michael D} and David Nutt and Abraham Weizman and Zhang, {Ming Rong} and Moshe Gavish",
year = "2006",
month = "8",
day = "1",
doi = "10.1016/j.tips.2006.06.005",
language = "English",
volume = "27",
pages = "402--409",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Translocator protein (18 kDa)

T2 - new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

AU - Papadopoulos, Vassilios

AU - Baraldi, Mario

AU - Guilarte, Tomás R.

AU - Knudsen, Thomas B.

AU - Lacapère, Jean Jacques

AU - Lindemann, Peter

AU - Norenberg, Michael D

AU - Nutt, David

AU - Weizman, Abraham

AU - Zhang, Ming Rong

AU - Gavish, Moshe

PY - 2006/8/1

Y1 - 2006/8/1

N2 - The peripheral-type benzodiazepine receptor or recognition site (PBR) is a widely distributed transmembrane protein that is located mainly in the outer mitochondrial membrane. The PBR binds to high-affinity drug ligands and cholesterol. Many functions are associated directly or indirectly with the PBR, including the regulation of cholesterol transport and the synthesis of steroid hormones, porphyrin transport and heme synthesis, apoptosis, cell proliferation, anion transport, regulation of mitochondrial functions and immunomodulation. Based on these functions, there are many potential clinical applications of PBR modulation, such as in oncologic, endocrine, neuropsychiatric and neurodegenerative diseases. Although 'PBR' is a widely used and accepted name in the scientific community, recent data regarding the structure and molecular function of this protein increasingly support renaming it to represent more accurately its subcellular role (or roles) and putative tissue-specific function (or functions). Translocator protein (18 kDa) is proposed as a new name, regardless of the subcellular localization of the protein.

AB - The peripheral-type benzodiazepine receptor or recognition site (PBR) is a widely distributed transmembrane protein that is located mainly in the outer mitochondrial membrane. The PBR binds to high-affinity drug ligands and cholesterol. Many functions are associated directly or indirectly with the PBR, including the regulation of cholesterol transport and the synthesis of steroid hormones, porphyrin transport and heme synthesis, apoptosis, cell proliferation, anion transport, regulation of mitochondrial functions and immunomodulation. Based on these functions, there are many potential clinical applications of PBR modulation, such as in oncologic, endocrine, neuropsychiatric and neurodegenerative diseases. Although 'PBR' is a widely used and accepted name in the scientific community, recent data regarding the structure and molecular function of this protein increasingly support renaming it to represent more accurately its subcellular role (or roles) and putative tissue-specific function (or functions). Translocator protein (18 kDa) is proposed as a new name, regardless of the subcellular localization of the protein.

UR - http://www.scopus.com/inward/record.url?scp=33746035655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746035655&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2006.06.005

DO - 10.1016/j.tips.2006.06.005

M3 - Article

C2 - 16822554

AN - SCOPUS:33746035655

VL - 27

SP - 402

EP - 409

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 8

ER -